Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 25 April 2022 Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Non-regulated information 21 April 2022 Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference Non-regulated information 21 April 2022 Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35% Regulated information 12 April 2022 Invitation to the Annual Shareholders’ Meeting Regulated information 31 March 2022 Biocartis Announces Publication of 2021 Annual Report Regulated information 24 February 2022 BIOCARTIS ANNOUNCES 2021 RESULTS AND 2022 OUTLOOK Regulated information 17 February 2022 BIOCARTIS ANNOUNCES 2021 FULL YEAR RESULTS ON 24 FEBRUARY 2022 Regulated information 8 February 2022 Biocartis and Ophiomics to Collaborate on Liver Cancer Test Non-regulated information 4 February 2022 Disclosure of a transparency notification Regulated information 25 January 2022 Large UK Study Shows Rapid EGFR Testing with Idylla™ Alongside NGS Has Potential to Enhance Lung Cancer Patient Health Outcomes Non-regulated information Pagination First page « First Previous page ‹‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page ›› Last page Last »